Retirement Planning Company of New England’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
Other funds holding IBB
WA
AFG
Retirement Planning Company of New England's IBB Position: Q2 2026 in Review
Retirement Planning Company of New England reduced its iShares Biotechnology ETF (IBB) stake by 2.9% in Q2 2026, selling an estimated $8.94K and leaving 1,720 shares worth $327K. The position accounts for 0.12% of the portfolio, ranked #188.
Retirement Planning Company of New England first reported a position in IBB in Q4 2021 and has held it in 19 quarters since. The position peaked at $422K in Q4 2021. 653 funds tracked by Wall St. Rank hold IBB as of Q2 2026.
- Retirement Planning Company of New England held 1,720 shares of iShares Biotechnology ETF worth $327K as of Q2 2026.
- Retirement Planning Company of New England sold 52 iShares Biotechnology ETF shares in Q2 2026, an estimated $8.94K.
- iShares Biotechnology ETF made up 0.12% of Retirement Planning Company of New England's portfolio in Q2 2026, its #188 holding.
- Retirement Planning Company of New England first reported a position in iShares Biotechnology ETF in Q4 2021 and has held it in 19 quarters since.
- Retirement Planning Company of New England's iShares Biotechnology ETF position peaked at $422K in Q4 2021.
- 653 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.
Based on Retirement Planning Company of New England's 13F filing for Q2 2026, filed 30 Jul 2026.